Literature DB >> 19710084

Hypoxia-induced hyperreactivity of pulmonary arteries: role of cyclooxygenase-2, isoprostanes, and thromboxane receptors.

Estelle Delannoy1, Arnaud Courtois, Véronique Freund-Michel, Véronique Leblais, Roger Marthan, Bernard Muller.   

Abstract

AIMS: This study investigates the role of the cyclooxygenase (COX)/prostanoid pathway in chronic hypoxia-induced hyperreactivity of pulmonary arteries. METHODS AND
RESULTS: Pulmonary arteries were removed from normoxic or hypoxic (0.5 atm for 21 days) mice and studied for protein expression/localization of COX-1, COX-2, and thromboxane A2 (TXA2)-synthase, release of TXA2, prostacyclin (PGI2) and the isoprostane 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha), and vasomotor responses. COX-2 expression was increased in all layers of pulmonary arteries from hypoxic mice. In contrast, COX-1 expression was not significantly modified following chronic hypoxia, whereas TXA2-synthase was decreased. Chronic hypoxia differentially affected prostanoid release from pulmonary arteries: TXA2 secretion was not significantly modified; PGI2 secretion was decreased, whereas 8-iso-PGF2alpha secretion was increased. A selective COX-2 inhibitor decreased 8-iso-PGF2alpha release. Arachidonic acid elicited an endothelium- and COX-1-dependent relaxation in pulmonary arteries from normoxic mice. In contrast, arachidonic acid induced an endothelium-independent contraction in pulmonary arteries from hypoxic mice that was partially reduced by catalase, COX-1, COX-2, or TXA2-synthase inhibitors and was totally abolished by blockade of the thromboxane (TP) receptor. Hyperresponsiveness to phenylephrine (PE) of pulmonary arteries from hypoxic mice was also decreased by COX-2 inhibitors, TP receptor antagonists or catalase, but not by TXA2-synthase inhibitors. Finally, 8-iso-PGF2alpha induced a TP receptor-dependent contraction in pulmonary arteries and markedly potentiated the contractile response to PE.
CONCLUSION: Chronic hypoxia up-regulates COX-2 expression, increases 8-iso-PGF2alpha release, and shifts arachidonic acid-induced, endothelium-dependent relaxation to an endothelium-independent and TP receptor-dependent contraction in pulmonary arteries. COX-2-dependent production of 8-iso-PGF2alpha, by activating TP receptors, participates in hypoxia-induced hyperreactivity of pulmonary arteries.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710084     DOI: 10.1093/cvr/cvp292

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  17 in total

Review 1.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

2.  EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling.

Authors:  Ankang Lu; Caojian Zuo; Yuhu He; Guilin Chen; Lingjuan Piao; Jian Zhang; Bing Xiao; Yujun Shen; Juan Tang; Deping Kong; Sara Alberti; Di Chen; Shenkai Zuo; Qianqian Zhang; Shuai Yan; Xiaochun Fei; Fei Yuan; Bin Zhou; Shengzhong Duan; Yu Yu; Michael Lazarus; Yunchao Su; Richard M Breyer; Colin D Funk; Ying Yu
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

Review 3.  Smooth muscle contractile diversity in the control of regional circulations.

Authors:  John J Reho; Xiaoxu Zheng; Steven A Fisher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-01       Impact factor: 4.733

Review 4.  NADPH oxidase-derived ROS and the regulation of pulmonary vessel tone.

Authors:  G Frazziano; H C Champion; P J Pagano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

5.  Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice.

Authors:  Yannis Hara; Yassine Sassi; Christelle Guibert; Natacha Gambaryan; Peter Dorfmüller; Saadia Eddahibi; Anne-Marie Lompré; Marc Humbert; Jean-Sébastien Hulot
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

Review 6.  Prenatal programming of pulmonary hypertension induced by chronic hypoxia or ductal ligation in sheep.

Authors:  Demosthenes G Papamatheakis; Madalitso Chundu; Arlin B Blood; Sean M Wilson
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 7.  Vascular Metabolic Mechanisms of Pulmonary Hypertension.

Authors:  Xiao-Fan Shi; Yun-Chao Su
Journal:  Curr Med Sci       Date:  2020-07-17

Review 8.  Endothelium-mediated control of vascular tone: COX-1 and COX-2 products.

Authors:  Michel Félétou; Yu Huang; Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

9.  Thromboxane receptor hyper-responsiveness in hypoxic pulmonary hypertension requires serine 324.

Authors:  K T Santhosh; A S Sikarwar; M Hinton; P Chelikani; S Dakshinamurti
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

10.  Increased endothelial microparticles and oxidative stress at extreme altitude.

Authors:  Jacqueline Pichler Hefti; Alexander Leichtle; Monika Stutz; Urs Hefti; Thomas Geiser; Andreas R Huber; Tobias M Merz
Journal:  Eur J Appl Physiol       Date:  2016-01-28       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.